Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    9518395 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Hematopoietic Stem Cell Transplantation in Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Procedure: Autologous hematopoietic stem cell transplantation
2 Completed
Has Results
Preferred Treatment of Type 1.5 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: rosiglitazone;   Drug: glyburide

Indicates status has not been verified in more than two years